Garret A. FitzGerald

机构：California University of Pennsylvania, Translational Therapeutics (United States), University of Pennsylvania · ORCID：0000-0002-5885-6819

发表论文 753 篇 · 总被引 70041 次 · h-index 133

代表论文

• Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples (2023 · Nature Communications · 被引 69)
• Technical recommendations for analyzing oxylipins by liquid chromatography–mass spectrometry (2025 · Science Signaling · 被引 46)
• Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis (2023 · Clinical and Translational Medicine · 被引 38)
• Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular-kidney-metabolic syndrome (2024 · Cell Metabolism · 被引 30)
• PGF2α signaling drives fibrotic remodeling and fibroblast population dynamics in mice (2023 · JCI Insight · 被引 28)
• Prostanoids in Cardiac and Vascular Remodeling (2024 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 24)